Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 14, Issue 4, 2008, Pages 768-775

  Keramat, Fariba ^a   Hashemi, S H ^a   Mamani, M ^a   Ranjbar, M ^a   Erfani, H ^b  

^a Sina Hospital Hamedan   (Iran)

^b Centre for Prevention and Control for Diseases   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FURAZOLIDONE; KANAMYCIN; NORFLOXACIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD GROUP TYPING; CHILD; CHOLERA; CROSS-SECTIONAL STUDY; EPIDEMIC; FECES CULTURE; FEMALE; HEALTH SURVEY; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SEROTYPE; VIBRIO CHOLERAE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; CHOLERA; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; HUMANS; INFANT; IRAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEROTYPING; SEX DISTRIBUTION; VIBRIO CHOLERAE;

EID: 53649097994     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Waldor MK et al. Cholera and other vibrios. In: Kasper DL et al., eds. Harrison's principles of internal medicine, 16th ed. New York, McGraw-Hill, 2005:909-12.
2. Seas C et al. Vibrio cholerae. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 6th ed. Philadelphia, Churchill Livingstone, 2005:2536-44.
3. Yamamato T et al. Survey of in vitro susceptibilities of Vibrio cholerae O1 and O 139 to antimicrobial agents. Antimicrobial agents and chemotherapy, 1995, 39:241-4.
4. Al-Abbassi AM, Ahmed S, Al-Hadithi T. Cholera epidemic in Baghdad during 1999: clinical and bacteriological profile of hospitalized cases. Eastern Mediterranean health journal, 2005, 11 (1/2):6-13.
5. Farme J et al. The prokaryotes. In: Blaws AG et al, eds. Handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, 2nd ed. New York, Springer-Verlag, 1992:2952-3011.
6. Tison D. Vibrio. In: Murray PR, Barron EJ, eds. Manual of clinical microbiology. Washington DC, ASM Press, 1999:497-506.
7. Bauer AW et al. Antibiotic susceptibility testing by standardized single disc method. American journal of clinical pathology, 1996, 45:493-6.
8. Cholera, 1998. Weekly epidemiological record, 1999, 74(31):257-64.
9. Cholera, 1999. Weekly epidemiological record, 2000, 75(31):249-26.
10. Cholera, 2000. Weekly epidemiological record, 2001, 76(31):233-40.
11. Keramat F et al. [A survey of etiologic, clinical manifestations and laboratory findings of patients with cholera in the Hamadan province epidemic in 1998]. Journal of Hamadan University of Medical Sciences, 2003,10(3):43-50 [in Farsi].
12. Kaistha N et al. Outbreak of cholera in and around Chandigarh during two successive years (2002, 2003). Indian journal of medicine research, 2005, 122:404-7.
13. Pourshafie M et al. A molecular and phenotypic study of Vibrio cholerae in Iran. Journal of medical microbiology, 2002, 51:392-8.
14. Singh J et al. Endemic cholera in Delhi 1995: analysis of data from a sentinel center. Journal of diarrhoeal diseases research, 1998, 16(2):66-73.
15. Sow Al et al. Diversite bacterienne au cours de l'epidemie de cholera a Dakar, Senegal (1995-1996) [Bacterial diversity during the cholera epidemic in Dakar, Senegal (1995-1996)]. Bulletin de la Societe de pathologie exotique, 1997, 90(3):160-1.
16. Sabeen F et al. In vitro susceptibility of Vibrio cholerae O1 biotype El Tor strains associated with an outbreak of cholera in Kerala, Southern India. Journal of antimicrobial chemotherapy, 2001, 47:361-2.
17. Urassa WK et al. Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania. East African medical journal, 2000, 77(7):350-3.
18. Gabastou JM et al. Caracteristicas de la epidemia de colera de 1998 en Ecuador, durante el fenomeno de "El Nino" [Characteristics of the cholera epidemic of 1998 in Ecuador during El Nino]. Revista panamericana de salud publiica, 2002, 12(3):157-64.
19. Garg P et al. Emergence of fluoroquinolone resistant strains of Vibrio cholerae O1 among hospitalized patient in Calcutta, India. Antimicrobial agents and chemotherapy, 2001, 45:1605-6.
20. Greenough WB et al. Tetracycline in the treatment of cholera. Lancet, 1964, 1:355.
21. O'Grady EM et al. Global surveillance of antibiotic sensitivity of Vibrio cholerae. Bulletin of the World Health Organization, 1976, 54:181.
22. Mukhopadhyay AK at al. Biotype traits and antibiotic susceptibility of Vibrio cholerae serogroup O1 before, during and after the emergence of the O139 serogroup. Epidemiology and infection, 1995, 115:427-34.
23. Hooper DC et al. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrobial agents and chemotherapy, 1985, 28:716-21.
24. Mukhopadhyay AK et al. Emergence of fluoroquinolone resistance in strains of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrobial agents and chemotherapy, 1998, 42:206-7.
25. Bhattacharya MK et al. Outbreak of cholera caused by Vibrio cholerae O1 intermediately resistant to norfloxacin at Malda, West Bengal. Journal of the Indian Medical Association, 2000, 98(7):389-90.